Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
Clinical trial NCT02308111 · TERMINATED
Trial details
- NCT number
- NCT02308111
- Sponsor
- Intercept Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-26
- Primary completion
- 2021-12-23
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.